Skip to content
10-Q

Quarterly Report

NovoCure Ltd NVCR

0001645113-25-000042

← back to feed
Filed
Oct 30, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 24, 2025 111.98M sh
Shares Diluted Q3 2025 · Sep 30, 2025 111.91M sh
Shares Diluted Q3 2025 · Sep 30, 2025 111.26M sh
Shares Diluted Q3 2025 · Dec 31, 2024 107.83M sh
Shares Diluted Q3 2025 · Sep 30, 2024 108.25M sh
Shares Diluted Q3 2025 · Sep 30, 2024 107.68M sh
Capex Q3 2025 · Sep 30, 2025 $5.66M
Capex Q3 2025 · Sep 30, 2025 $21.75M
Capex Q3 2025 · Dec 31, 2024 $42.86M
Capex Q3 2025 · Sep 30, 2024 $10.68M
Capex Q3 2025 · Sep 30, 2024 $33.91M
Operating Cash Flow Q3 2025 · Sep 30, 2025 $20.57M
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$31.03M
Operating Cash Flow Q3 2025 · Dec 31, 2024 −$26.37M
Operating Cash Flow Q3 2025 · Sep 30, 2024 $10.38M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$22.92M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $342.12M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $163.77M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $185.42M
Stockholders Equity Q3 2025 · Sep 30, 2025 $341.33M
Stockholders Equity Q3 2025 · Jun 30, 2025 $349.44M
Stockholders Equity Q3 2025 · Mar 31, 2025 $361.96M
Stockholders Equity Q3 2025 · Dec 31, 2024 $360.18M
Stockholders Equity Q3 2025 · Sep 30, 2024 $360.78M
Stockholders Equity Q3 2025 · Jun 30, 2024 $361.75M
Stockholders Equity Q3 2025 · Mar 31, 2024 $359.36M
Stockholders Equity Q3 2025 · Dec 31, 2023 $362.5M
Current Liabilities Q3 2025 · Sep 30, 2025 $776.01M
Current Liabilities Q3 2025 · Dec 31, 2024 $756.38M
Total Liabilities Q3 2025 · Sep 30, 2025 $1.02B
Total Liabilities Q3 2025 · Dec 31, 2024 $880.61M
Current Assets Q3 2025 · Sep 30, 2025 $1.2B
Current Assets Q3 2025 · Dec 31, 2024 $1.11B
Total Assets Q3 2025 · Sep 30, 2025 $1.36B
Total Assets Q3 2025 · Dec 31, 2024 $1.24B
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.33
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.00
Eps Diluted Q3 2025 · Dec 31, 2024 −$1.56
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.28
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.95
Eps Basic Q3 2025 · Sep 30, 2025 −$0.33
Eps Basic Q3 2025 · Sep 30, 2025 −$1.00
Eps Basic Q3 2025 · Dec 31, 2024 −$1.56
Eps Basic Q3 2025 · Sep 30, 2024 −$0.28
Eps Basic Q3 2025 · Sep 30, 2024 −$0.95
Sga Expense Q3 2025 · Sep 30, 2025 $45.92M
Sga Expense Q3 2025 · Sep 30, 2025 $134.65M
Sga Expense Q3 2025 · Dec 31, 2024 $189.83M
Sga Expense Q3 2025 · Sep 30, 2024 $40.1M
Sga Expense Q3 2025 · Sep 30, 2024 $117.34M
Rd Expense Q3 2025 · Sep 30, 2025 $54.03M
Rd Expense Q3 2025 · Sep 30, 2025 $163.64M
Rd Expense Q3 2025 · Dec 31, 2024 $209.65M
Rd Expense Q3 2025 · Sep 30, 2024 $51.88M
Rd Expense Q3 2025 · Sep 30, 2024 $158.44M
Net Income Q3 2025 · Sep 30, 2025 −$37.27M
Net Income Q3 2025 · Sep 30, 2025 −$111.73M
Net Income Q3 2025 · Jun 30, 2025 −$40.14M
Net Income Q3 2025 · Mar 31, 2025 −$34.32M
Net Income Q3 2025 · Dec 31, 2024 −$168.63M
Net Income Q3 2025 · Sep 30, 2024 −$30.57M
Net Income Q3 2025 · Sep 30, 2024 −$102.71M
Net Income Q3 2025 · Jun 30, 2024 −$33.38M
Net Income Q3 2025 · Mar 31, 2024 −$38.76M
Operating Income Q3 2025 · Sep 30, 2025 −$36.02M
Operating Income Q3 2025 · Sep 30, 2025 −$113.41M
Operating Income Q3 2025 · Dec 31, 2024 −$170.5M
Operating Income Q3 2025 · Sep 30, 2024 −$32.09M
Operating Income Q3 2025 · Sep 30, 2024 −$107.19M
Gross Profit Q3 2025 · Sep 30, 2025 $122.48M
Gross Profit Q3 2025 · Sep 30, 2025 $356.28M
Gross Profit Q3 2025 · Dec 31, 2024 $468.04M
Gross Profit Q3 2025 · Sep 30, 2024 $119.72M
Gross Profit Q3 2025 · Sep 30, 2024 $340.24M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $44.73M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $124.72M
Cost Of Revenue Q3 2025 · Dec 31, 2024 $137.18M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $35.37M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $103.72M
Revenue Q3 2025 · Sep 30, 2025 $167.2M
Revenue Q3 2025 · Sep 30, 2025 $481M
Revenue Q3 2025 · Dec 31, 2024 $605.22M
Revenue Q3 2025 · Sep 30, 2024 $155.1M
Revenue Q3 2025 · Sep 30, 2024 $443.95M